Regulation & Compliance

As instant payment fraud soars, a new partnership between Sardine and Modulr integrates advanced AI to protect billions in transactions in real-time.

Anduin launches Instant Extraction, using AI to digitize offline investor documents, aiming to end the era of manual data entry for fund managers.

Investment firm Malar Group backs wellness startup Attaboy Labs, betting on clinical science over marketing hype in the booming supplement industry.

A new report reveals fraud is now a coordinated industry, with phishing as its main engine, making old defenses obsolete and costing businesses billions.

Berlin-based Tacalyx is advancing its lead drug, TCX-201, to the clinic, targeting a novel class of antigens once thought impossible to drug.

OSIbeyond's new subscription service eliminates massive upfront compliance costs, leveling the field for defense contractors facing mandatory CMMC rules.

Major League Soccer selects five AI startups for its Innovation Lab, aiming to transform player health, fan experience, and media ahead of the 2026 World Cup.

EY and Rillet partner on an AI-native finance platform, promising modernization without disruption and embedding risk controls from the very start.

New Orleans-based Stokes Family Office surpasses $3.3B in assets, expanding into Dallas and investing in a new flagship headquarters ahead of its 40th anniversary.

The new platform unifies AI agents, telephony, email, and quoting, offering independent agencies a single, compliant, autonomous operating system.

As AI-driven attacks breach networks in minutes, a new certification highlights the urgent need to secure the forgotten frontier: internal 'east-west' traffic.

The brokerage firm now offers highly leveraged crypto CFD trading. How does this service stack up in a competitive market with evolving regulations?

A new advisory firm is tackling the opaque world of aesthetic device sales, promising to save providers up to $80,000 on high-ticket equipment.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

A new campaign aims to save a major research hub, igniting a debate over its economic benefits, medical breakthroughs, and the future of animal testing.

Scholar Hotels is launching a $5,000 minimum investment platform for its State College properties, tapping into alumni loyalty and a new era of retail investing.

A new partnership brings mask-free sleep apnea therapy to veterans, aligning with updated DoD/VA guidelines that prioritize patient preference and comfort.

After 16 years of growth and modernization, Executive Director Darren Gilmour steps down, leaving Canada's national academy at a pivotal crossroads.

With a fourfold revenue jump, China's Yangtze River Pharmaceutical Group isn't just selling drugs; it's exporting a new model of global trust and quality.

Amid surging recurring revenue and a booming cybersecurity market, Allot's leadership prepares to outline its ambitious growth strategy for 2026 to investors.